Skip to content

Clinical trials

Phase 1/2 trials in Latvia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Country / region: Latvia Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20141
20151
20171
20182
20201
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ablynx, a Sanofi company1
Boehringer Ingelheim1
Cantargia AB1
Immatics Biotechnologies GmbH1
Novartis Pharmaceuticals1
Opthea Limited1
Orion Corporation, Orion Pharma1
PanOptica, Inc.1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colorectal Neoplasms2
Carcinoma, Non-Small-Cell Lung1
Diabetic Retinopathy1
Macular Degeneration1
Neoplasms1
Prostatic Neoplasms1
Pulmonary Arterial Hypertension1
Respiratory Syncytial Virus Infections1
Triple Negative Breast Neoplasms1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.